Enanta Pharmaceuticals (ENTA) Receivables - Other (2012 - 2015)
Enanta Pharmaceuticals' (ENTA) quarterly Receivables - Other came in at $1.0 million in Q4 2015, down 46.39% YoY from $1.9 million in Q4 2014, and up 133.03% on a QoQ basis from $433000.0 in Q3 2015.
Enanta Pharmaceuticals (ENTA) Receivables - Other (2012 - 2015) Analysis & Trends
Enanta Pharmaceuticals (ENTA) has 4 years of Receivables - Other data on file, last reported at $1.0 million in Q4 2015.
- Quarterly Receivables - Other fell 46.39% year-over-year to $1.0 million in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $1.0 million (down 46.39% YoY) and the FY2015 annual result came in at $433000.0, down 84.37% from the prior year.
- Receivables - Other climbed to $1.0 million in Q4 2015, from $433000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $2.8 million in Q3 2014 to a low of $433000.0 in Q3 2015.
- A 4-year average of $1.4 million and a median of $1.4 million in 2015 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2014 — Receivables - Other jumped 253.32% — and 2015, when it sank 84.37%.
- Tracing ENTA's Receivables - Other over 4 years: stood at $1.7 million in 2012, then slumped by 44.3% to $929000.0 in 2013, then jumped by 102.58% to $1.9 million in 2014, then plunged by 46.39% to $1.0 million in 2015.
- The last three Receivables - Other figures came in at $1.0 million (Q4 2015), $433000.0 (Q3 2015), and $1.4 million (Q2 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Enanta Pharmaceuticals | 383.29 Mn | 193.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 1.01 Mn |
| Dec 31, 2015 | 1.01 Mn |
| Sep 30, 2015 | 433,000.00 |
| Sep 30, 2015 | 433,000.00 |
| Jun 30, 2015 | 1.38 Mn |
| Jun 30, 2015 | 1.38 Mn |
| Mar 31, 2015 | 1.55 Mn |
| Mar 31, 2015 | 1.55 Mn |
| Dec 31, 2014 | 1.88 Mn |
| Dec 31, 2014 | 1.88 Mn |
| Sep 30, 2014 | 2.77 Mn |
| Sep 30, 2014 | 2.77 Mn |
| Jun 30, 2014 | 2.26 Mn |
| Jun 30, 2014 | 2.26 Mn |
| Mar 31, 2014 | 1.60 Mn |
| Mar 31, 2014 | 1.60 Mn |
| Dec 31, 2013 | 929,000.00 |
| Dec 31, 2013 | 929,000.00 |
| Sep 30, 2013 | 784,000.00 |
| Sep 30, 2013 | 784,000.00 |